BTLS logo

Biotalys NV Stock Price

ENXTBR:BTLS Community·€183.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

BTLS Share Price Performance

€4.89
1.81 (58.77%)
€4.89
1.81 (58.77%)
Price €4.89

BTLS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

Biotalys NV Key Details

€0

Revenue

€0

Cost of Revenue

€0

Gross Profit

€14.8m

Other Expenses

-€14.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 19, 2026
-0.40
0%
0%
11.3%
View Full Analysis

About BTLS

Founded
2013
Employees
63
CEO
Kevin Helash
WebsiteView website
biotalys.com

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN-4 targeting oomycetes in fruits and vegetables; BIOFUN-8 targeting altenaria in fruits, vegetables, and specialty crops; and BioIns-2 targeting key insect pests. The company was formerly known as Agrosavfe NV and changed its name to Biotalys NV in December 2019. Biotalys NV was incorporated in 2013 and is headquartered in Gent, Belgium.

Recent BTLS News & Updates

Recent updates

No updates